Smith & Nephew plc (SN.L)
SN.L Stock Price Chart
Explore Smith & Nephew plc interactive price chart. Choose custom timeframes to analyze SN.L price movements and trends.
SN.L Company Profile
Discover essential business fundamentals and corporate details for Smith & Nephew plc (SN.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
1 Jul 1988
Employees
17.35K
Website
https://www.smith-nephew.comCEO
Deepak S. Nath
Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
SN.L Financial Timeline
Browse a chronological timeline of Smith & Nephew plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Feb 2026
Upcoming earnings on 23 Feb 2026
Dividend declared on 2 Oct 2025
A dividend of £11.14 per share was announced, adjusted to £11.14. The dividend will be paid on 7 Nov 2025.
Earnings released on 5 Aug 2025
EPS came in at £0.31 matching the estimated £0.31, while revenue for the quarter reached £2.16B , beating expectations by +42.97%.
Earnings released on 30 Apr 2025
Dividend declared on 27 Mar 2025
A dividend of £17.48 per share was announced, adjusted to £17.48. The dividend was paid on 28 May 2025.
Earnings released on 25 Feb 2025
EPS came in at £0.37 surpassing the estimated £0.37 by +1.70%, while revenue for the quarter reached £2.37B , beating expectations by +0.70%.
Earnings released on 31 Oct 2024
Dividend declared on 3 Oct 2024
A dividend of £14.40 per share was announced, adjusted to £14.40. The dividend was paid on 8 Nov 2024.
Earnings released on 1 Aug 2024
EPS came in at £0.10 falling short of the estimated £0.31 by -68.85%, while revenue for the quarter reached £1.12B , missing expectations by -0.21%.
Earnings released on 1 May 2024
EPS came in at £0.10 , while revenue for the quarter reached £1.13B , missing expectations by -1.92%.
Dividend declared on 28 Mar 2024
A dividend of £23.10 per share was announced, adjusted to £23.10. The dividend was paid on 22 May 2024.
Earnings released on 27 Feb 2024
EPS came in at £0.38 falling short of the estimated £0.38 by -1.02%, while revenue for the quarter reached £1.11B , missing expectations by -49.51%.
Earnings released on 2 Nov 2023
EPS came in at £0.04 , while revenue for the quarter reached £1.16B , beating expectations by +0.11%.
Dividend declared on 5 Oct 2023
A dividend of £11.89 per share was announced, adjusted to £11.89. The dividend was paid on 1 Nov 2023.
Earnings released on 3 Aug 2023
EPS came in at £0.08 falling short of the estimated £0.29 by -73.05%, while revenue for the quarter reached £1.08B , missing expectations by -9.53%.
Earnings released on 26 Apr 2023
EPS came in at £0.08 , while revenue for the quarter reached £1.11B , missing expectations by -19.18%.
Earnings released on 21 Feb 2023
EPS came in at £0.02 falling short of the estimated £0.30 by -92.86%, while revenue for the quarter reached £1.07B , missing expectations by -3.28%.
Dividend declared on 21 Feb 2023
A dividend of £18.38 per share was announced, adjusted to £18.38. The dividend was paid on 17 May 2023.
Earnings released on 3 Nov 2022
EPS came in at £0.02 , while revenue for the quarter reached £1.18B .
Earnings released on 28 Jul 2022
EPS came in at £0.08 falling short of the estimated £0.31 by -73.23%, while revenue for the quarter reached £1.07B , missing expectations by -50.20%.
Dividend declared on 28 Jul 2022
A dividend of £12.00 per share was announced, adjusted to £12.91. The dividend was paid on 26 Oct 2022.
Earnings released on 28 Apr 2022
EPS came in at £0.08 , while revenue for the quarter reached £990.53M .
Earnings released on 22 Feb 2022
EPS came in at £0.13 falling short of the estimated £0.32 by -58.14%, while revenue for the quarter reached £968.48M , missing expectations by -49.98%.
Dividend declared on 22 Feb 2022
A dividend of £18.40 per share was announced, adjusted to £18.40. The dividend was paid on 11 May 2022.
Earnings released on 4 Nov 2021
EPS came in at £0.13 , while revenue for the quarter reached £967.04M .
Earnings released on 29 Jul 2021
EPS came in at £0.08 falling short of the estimated £0.29 by -70.43%, while revenue for the quarter reached £940.77M , missing expectations by -50.90%.
Dividend declared on 29 Jul 2021
A dividend of £10.50 per share was announced, adjusted to £10.50. The dividend was paid on 27 Oct 2021.
Earnings released on 29 Apr 2021
EPS came in at £0.08 , while revenue for the quarter reached £940.27M .
Earnings released on 18 Feb 2021
EPS came in at £0.15 falling short of the estimated £0.33 by -56.63%, while revenue for the quarter reached £927.32M , missing expectations by -49.93%.
Dividend declared on 18 Feb 2021
A dividend of £16.62 per share was announced, adjusted to £16.62. The dividend was paid on 12 May 2021.
Earnings released on 29 Oct 2020
EPS came in at £0.15 , while revenue for the quarter reached £977.89M .
Dividend declared on 29 Jul 2020
A dividend of £11.07 per share was announced, adjusted to £11.07. The dividend was paid on 28 Oct 2020.
SN.L Stock Performance
Access detailed SN.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.